Increasing incidence of lung transplantation in patients with post-COVID-19 pulmonary fibrosis.
Pan Afr Med J
; 40: 169, 2021.
Статья
в английский
| MEDLINE | ID: covidwho-1566818
ABSTRACT
Twenty months into the COVID-19 pandemic, we are still learning about the various long-term consequences of COVID-19 infection. While many patients do recover with minimal long-term consequences, some patients develop irreversible parenchymal and interstitial lung damage leading to diffuse pulmonary fibrosis. Unfortunately, these are some of the consequences of post-SARS-CoV-2 infection which thousands more people around the world will experience and which will outlast the pandemic for a long time to come. It is now being observed at various leading medical centres around the world that lung transplantation may be the only meaningful treatment available to a select group of patients experiencing serious lung damage and non-resolving COVID-19-associated respiratory failure, resulting from the triad of coronavirus infection, a hyper-inflammatory immune response to it and the inability of the human body to repair that injury.
ключевые слова
Полный текст:
Имеется в наличии
Коллекция:
Международные базы данных
база данных:
MEDLINE
Основная тема:
Pulmonary Fibrosis
/
Lung Transplantation
/
COVID-19
Тип исследования:
Наблюдательное исследование
Темы:
Длинный Ковид
Пределы темы:
Люди
Язык:
английский
Журнал:
Pan Afr Med J
Год:
2021
Тип:
Статья
Аффилированная страна:
Pamj.2021.40.169.31223
Документы, близкие по теме
MEDLINE
...
LILACS
LIS